1,721,158 research outputs found
Choosing troponin immunoassays in a world of limited resources.
No full textChoosing troponin immunoassays in a world of limited resources
Standardised designation of commercial troponin immunoassays.
No full textStandardised designation of commercial troponin immunoassays
Letter by Lippi and Cervellin Regarding Article, "High-sensitivity Cardiac Troponin in the Distinction of Acute Myocardial Infarction From Acute Cardiac Noncoronary Artery Disease".
No full textHigh-sensitivity Cardiac Troponin in the Distinction of Acute Myocardial Infarction From Acute Cardiac Noncoronary Artery Disease
Challenges of serial troponin testing: An unfinished symphony.
No full textChallenges of serial troponin testing: An unfinished symphony
Neutrophil gelatinase-associated lipocalin: a more specific assay is needed for diagnosing renal injury.
No full textNeutrophil gelatinase-associated lipocalin: a more specific assay is needed for diagnosing renal injury
Identification of troponin determinants for improving its diagnostic performance in the emergency department
No full textIdentification of Troponin Determinants for Improving its Diagnostic Performance in the Emergency Department
Neutrophil Gelatinase-Associated Lipocalin (NGAL), neutrophils and chronic kidney disease: which comes first?
No full textNeutrophil Gelatinase-Associated Lipocalin (NGAL), neutrophils and chronic kidney disease: which comes first
Assay Characteristics and Diagnostic Improvement from Contemporary to High-sensitivity Troponin I Immunoassays.
No full textAssay Characteristics and Diagnostic Improvement from Contemporary to High-sensitivity Troponin I Immunoassays
Of MIs and Men-A Historical Perspective on the Diagnostics of Acute Myocardial Infarction.
No full textThe history of myocardial infarction (MI) diagnostics has gone through a continuous evolution over the past century, when several new discoveries have contributed to remarkably increase the number of patients appropriately diagnosed with this condition. The tale "of MIs and Men" displays rather a long history, since atherosclerosis was found to be present in humans several centuries before modern civilization and the identification of the most prevalent risk factors. It was only at the end of the 19th century and at the beginning of the 20th century that the physicians acknowledged that MI is principally sustained by coronary thrombosis, and that the clinical picture of MI could be subsequently confirmed at autopsy. With the first description of the electrocardiogram (ECG) in the 1910s and 1920s, the history of modern MI diagnostics really began. Additional important discoveries followed, which are mainly represented by radiography, echocardiography, computed tomography, and magnetic resonance imaging of the heart. Another major breakthrough occurred at the down of the third millennium, with the development of commercial immunoassays for the measurement of cardiac troponin I and T, which represent now the cornerstones for identifying any kind of myocardial injury, thus including MI. The major advancements in the understanding of MI pathophysiology and the progressive introduction of efficient diagnostic tools will be described and discussed in this narrative historical review
The Assessment of C-Reactive Protein Does Not Improve the Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin Immunoassay.
No full textThe Assessment of C-Reactive Protein Does Not Improve the Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin Immunoassay
- …
